Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health
This executive order establishes a National Influenza Vaccine Task Force co-chaired by Defense and HHS to modernize U.S. influenza vaccine production away from egg-based methods toward faster, scalable cell-based and recombinant technologies. It mandates a 5-year national plan and directs multiple agencies to estimate costs, expand manufacturing capacity, and accelerate development of broadly protective vaccines.